The Discounted Cash Flow (DCF) valuation of Revance Therapeutics Inc (RVNC) is (372.41) USD. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on DCF is -10302.9%.
Based on the latest price of 3.65 USD and our DCF valuation, Revance Therapeutics Inc (RVNC) is a sell. selling RVNC stocks now will result in a potential gain of 10302.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.1% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (772.31) - (250.49) | (372.41) |
| Upside | -21259.1% - -6962.8% | -10302.9% |